National Bank of Canada
FLNA

National Bank of Canada’s Filana Therapeutics FLNA Stock Holding History

National Bank of Canada’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89K Buy
1,710
+200
+13% +$412 ﹤0.01% 2567
2025
Q4 		$2.98K Hold
1,510
– – ﹤0.01% 2521
2025
Q3 		$4.36K Sell
1,510
-10
-0.7% -$23 ﹤0.01% 2476
2025
Q2 		$2.75K Sell
1,520
-200,370
-99% -$357K ﹤0.01% 2580
2025
Q1 		$303K Sell
201,890
-261,300
-56% -$659K ﹤0.01% 1434
2024
Q4 		$1.09M Buy
463,190
+367,899
+386% +$6.46M ﹤0.01% 1292
2024
Q3 		$2.8M Sell
95,291
-128,309
-57% -$2.95M ﹤0.01% 944
2024
Q2 		$2.71M Buy
223,600
+218,400
+4,200% +$4.6M ﹤0.01% 876
2024
Q1 		$105K Sell
5,200
-259,110
-98% -$5.97M ﹤0.01% 1543
2023
Q4 		$5.93M Buy
264,310
+148,000
+127% +$3.13M 0.01% 707
2023
Q3 		$1.95M Buy
116,310
+115,700
+18,967% +$2.29M ﹤0.01% 1044
2023
Q2 		$14.9K Hold
610
– – ﹤0.01% 2083
2023
Q1 		$14.7K Sell
610
-50
-8% -$1.39K ﹤0.01% 2050
2022
Q4 		$19.5K Sell
660
-19,800
-97% -$712K ﹤0.01% 2005
2022
Q3 		$855K Buy
20,460
+20,185
+7,340% +$545K ﹤0.01% 1029
2022
Q2 		$8K Sell
275
-117,835
-100% -$2.98M ﹤0.01% 2328
2022
Q1 		$4.39M Sell
118,110
-74,230
-39% -$3.15M 0.01% 654
2021
Q4 		$8.4M Buy
+192,340
New +$10.1M 0.03% 430

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

National Bank of Canada's FLNA Position: Q1 2026 in Review

National Bank of Canada increased its Filana Therapeutics (FLNA) stake by 13% in Q1 2026, buying an estimated $412 and bringing the position to 1,710 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

National Bank of Canada first reported a position in FLNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.4M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • National Bank of Canada held 1,710 shares of Filana Therapeutics worth $2.89K as of Q1 2026.
  • National Bank of Canada bought 200 Filana Therapeutics shares in Q1 2026, an estimated $412.
  • Filana Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2567 holding.
  • National Bank of Canada first reported a position in Filana Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Filana Therapeutics position peaked at $8.4M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.